Transcene Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	312.22	200.22	124.76
Revenue Growth (YoY)	113.51%	60.48%	-
Cost of Revenue	219.42	180.22	102.17
Gross Profit	92.79	20	22.6
Selling, General & Admin	68.57	68.4	49.56
Research & Development	20.59	25.43	66.63
Operating Expenses	90.56	95.73	115.93
Operating Income	2.24	-75.72	-93.34
Interest Expense	-19.01	-15.61	-5.73
Interest & Investment Income	0.9	0.92	0.83
Currency Exchange Gain (Loss)	-0.49	0.69	0.42
Other Non Operating Income (Expenses)	0.57	1.6	2.72
EBT Excluding Unusual Items	-16.66	-88.13	-95.1
Gain (Loss) on Sale of Assets	-	-0.01	-0.37
Pretax Income	-16.66	-88.14	-95.47
Income Tax Expense	-0.8	-9.27	-7.95
Net Income	-15.87	-78.87	-87.52
Net Income to Common	-15.87	-78.87	-87.52
Shares Outstanding (Basic)	38	37	32
Shares Outstanding (Diluted)	38	37	32
Shares Change (YoY)	6.79%	14.53%	-
EPS (Basic)	-0.42	-2.15	-2.74
EPS (Diluted)	-0.42	-2.15	-2.74
Free Cash Flow	8.39	-171.95	-448.43
Free Cash Flow Per Share	0.22	-4.70	-14.03
Gross Margin	29.72%	9.99%	18.11%
Operating Margin	0.72%	-37.82%	-74.81%
Profit Margin	-5.08%	-39.39%	-70.15%
Free Cash Flow Margin	2.69%	-85.88%	-359.42%
EBITDA	74.06	-27.05	-67.14
EBITDA Margin	23.72%	-13.51%	-53.81%
D&A For EBITDA	71.82	48.68	26.2
EBIT	2.24	-75.72	-93.34
EBIT Margin	0.72%	-37.82%	-74.81%

Source: S&P Capital IQ. Standard template. Financial Sources.